Videos
Experts in breast oncology review 4 clinical cases and discuss individualized treatment approaches for each patient.
Kerry Rogers, MD, discusses an important unmet need in patients with hairy cell leukemia.
Tatyana Feldman, MD, discusses the design and efficacy of the ECHELON-1 trial investigating brentuximab vedotin with chemotherapy in patients with stage III or IV Hodgkin lymphoma after a 3-year update.
Alexey V. Danilov, MD, PhD, discusses a treatment regimen of venetoclax plus rituximab used for patients with chronic lymphocytic leukemia the 2019 American Society of Hematology Annual Meeting.
Robert L. Ferris, MD, PhD, discusses the rationale for evaluating STING agonists as treatment for patients with head and neck cancers.
Bradley McGregor, MD, discusses a small study that evaluated the combination of atezolizumab and bevacizumab for the treatment of patients with non-clear cell renal cell carcinoma.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Tec/Dara Offers a Path Forward in Relapsed Myeloma When CAR T Is Not an Option
2
FDA Approves Capivasertib Plus Abiraterone and Prednisone for PTEN-Deficient Prostate Cancer
3
FDA Grants Fast Track Designation to Ofirnoflast for Lower-Risk MDS
4
The Gap Between What Oncologists Have Been Prescribing and What the ROS1 Data Now Supports
5